<- Go Home

Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Market Cap

$8.1B

Volume

1.6M

Cash and Equivalents

$127.0M

EBITDA

$1.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$4.0B

Profit Margin

31.60%

52 Week High

$82.49

52 Week Low

$60.56

Dividend

N/A

Price / Book Value

2.45

Price / Earnings

20.64

Price / Tangible Book Value

-4.84

Enterprise Value

$12.6B

Enterprise Value / EBITDA

10.70

Operating Income

$761.0M

Return on Equity

8.47%

Return on Assets

4.61

Cash and Short Term Investments

$127.0M

Debt

$3.2B

Equity

$4.7B

Revenue

$12.7B

Unlevered FCF

$633.6M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches